NEW YORK (GenomeWeb News) – Gene Network Sciences will process clinical data from Biogen Idec to identify targets and biomarkers for inflammation, GNS said today.
GNS will use the data to develop a forward-simulation model that Biogen will then license.
GNS uses massively parallel supercomputers to search through “vast amounts of raw human biological data” for causes of disease and information about disease treatment, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.